Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/196110
Title: | Persistent COVID-19 symptoms 1 year after hospital discharge: A prospective multicenter study |
Author: | Aranda, Judit Oriol, Isabel Feria, Lucía Abelenda, Gabriela Rombauts, Alexander Simonetti, Antonella Francesca Catalano, Clarisa Pallarès, Natàlia Martín, Miguel Vàzquez, Núria Vall Llosera, Estel Rhyman, Nicolás Suárez, Romina Concepción Nogué, Marta Loureiro Amigo, Jose Coloma, Ana Ceresuela, Luis Carratalà, Jordi |
Keywords: | Pandèmia de COVID-19, 2020- Epidemiologia Símptomes Rehabilitació mèdica COVID-19 Pandemic, 2020- Epidemiology Symptoms Medical rehabilitation |
Issue Date: | 10-Oct-2022 |
Publisher: | Public Library of Science (PLoS) |
Abstract: | Objective To determine the health status and exercise capacity of COVID-19 survivors one year after hospital discharge. Methods This multicenter prospective study included COVID-19 survivors 12 months after hospital discharge. Participants were randomly selected from a large cohort of COVID-19 patients who had been hospitalized until 15th April 2020. They were interviewed about persistent symptoms, underwent a physical examination, chest X-ray, and a 6-minute walk test (6MWT). A multivariate analysis was performed to determine the risk factors for persistent dyspnea. Results Of the 150 patients included, 58% were male and the median age was 63 (IQR 54-72) years. About 82% reported >= 1 symptoms and 45% had not recovered their physical health. The multivariate regression analysis revealed that the female sex, chronic obstructive pulmonary disease, and smoking were independent risk factors for persistent dyspnea. Approximately 50% completed less than 80% of the theoretical distance on the 6MWT. Only 14% had an abnormal X-ray, showing mainly interstitial infiltrates. A third of them had been followed up in outpatient clinics and 6% had undergone physical rehabilitation. Conclusion Despite the high rate of survivors of the first wave of the COVID-19 pandemic with persistent symptomatology at 12 months, the follow-up and rehabilitation of these patients has been really poor. Studies focusing on the role of smoking in the persistence of COVID-19 symptoms are lacking. |
Note: | Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0275615 |
It is part of: | PLOS ONE, 2022, vol. 17, num. 10, p. e0275615 |
URI: | http://hdl.handle.net/2445/196110 |
Related resource: | https://doi.org/10.1371/journal.pone.0275615 |
ISSN: | 1932-6203 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) Articles publicats en revistes (Ciències Clíniques) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
journal.pone.0275615 (1).pdf | 460.15 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License